These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 1612231

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Heterogeneity of islet cell cytoplasmic antibodies and autoantibodies to glutamate decarboxylase in relatives of patients with type 1 (insulin-dependent) diabetes.
    Bergerot I, Souchier C, Thivolet C.
    C R Acad Sci III; 1993 Nov; 316(11):1368-73. PubMed ID: 8087616
    [Abstract] [Full Text] [Related]

  • 6. Associations of anti-GAD antibodies with islet cell antibodies and insulin autoantibodies in first-degree relatives of type I diabetic patients.
    Roll U, Christie MR, Standl E, Ziegler AG.
    Diabetes; 1994 Jan; 43(1):154-60. PubMed ID: 8262311
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Risk for developing type 1 (insulin-dependent) diabetes mellitus and the presence of islet 64K antibodies.
    Bärmeier H, McCulloch DK, Neifing JL, Warnock G, Rajotte RV, Palmer JP, Lernmark A.
    Diabetologia; 1991 Oct; 34(10):727-33. PubMed ID: 1959705
    [Abstract] [Full Text] [Related]

  • 10. Combined analysis of islet cell antibodies which cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in subjects at risk for IDDM.
    Chaillous L, Delamaire M, Elmansour A, Maugendre D, Rohmer V, Joseph MG, Lecomte P, Limal JM, Charbonnel B, Allannic H.
    Diabetologia; 1994 May; 37(5):491-9. PubMed ID: 8056187
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Autoantibodies and high-risk HLA susceptibility markers in first-degree relatives of Brazilian patients with type 1 diabetes mellitus: a progression to disease based study.
    Alves LI, Davini E, Correia MR, Fukui RT, Santos RF, Cunha MR, Rocha DM, Volpini WM, Silva ME.
    J Clin Immunol; 2012 Aug; 32(4):778-85. PubMed ID: 22402866
    [Abstract] [Full Text] [Related]

  • 13. Combined analysis of islet cell antibodies that cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in type I diabetic patients.
    Chaillous L, Delamaire M, Martignat L, Maugendre D, Marre M, Mathieu E, Limal JM, Charbonnel B, Allannic H, Saï P.
    Diabetes Care; 1994 Oct; 17(10):1115-23. PubMed ID: 7821130
    [Abstract] [Full Text] [Related]

  • 14. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM, Deschamps I, Garchon HJ, Roussely H, Moreau N, Beaurain G, Robert JJ, Bach JF.
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [Abstract] [Full Text] [Related]

  • 15. Antibodies to glutamic acid decarboxylase in Australian children with insulin-dependent diabetes mellitus and their first-degree relatives.
    Chen QY, Rowley MJ, Byrne GC, Jones TW, Tuomi T, Knowles WJ, Zimmet PZ, Mackay IR.
    Pediatr Res; 1993 Dec; 34(6):785-90. PubMed ID: 8108194
    [Abstract] [Full Text] [Related]

  • 16. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives.
    Bingley PJ, Christie MR, Bonifacio E, Bonfanti R, Shattock M, Fonte MT, Bottazzo GF, Gale EA.
    Diabetes; 1994 Nov; 43(11):1304-10. PubMed ID: 7926304
    [Abstract] [Full Text] [Related]

  • 17. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry.
    Gorus FK, Goubert P, Semakula C, Vandewalle CL, De Schepper J, Scheen A, Christie MR, Pipeleers DG.
    Diabetologia; 1997 Jan; 40(1):95-9. PubMed ID: 9028724
    [Abstract] [Full Text] [Related]

  • 18. Autoantibody negative new onset type 1 diabetic patients lacking high risk HLA alleles in a caucasian population: are these type 1b diabetes cases?
    Tiberti C, Buzzetti R, Anastasi E, Dotta F, Vasta M, Petrone A, Cervoni M, Torresi P, Vecci E, Multari G, Di Mario U.
    Diabetes Metab Res Rev; 2000 Jan; 16(1):8-14. PubMed ID: 10707033
    [Abstract] [Full Text] [Related]

  • 19. Limited loss of tolerance to islet autoantigens in ICA+ first degree relatives of patients with type I diabetes expressing the HLA dqb1*0602 allele.
    Gianani R, Verge CF, Moromisato-Gianani RI, Yu L, Zhang YJ, Pugliese A, Eisenbarth GS.
    J Autoimmun; 1996 Jun; 9(3):423-5. PubMed ID: 8816981
    [Abstract] [Full Text] [Related]

  • 20. [Evaluation of the importance of antibodies against islet cells (ICA) and Glutamate Decarboxylase(anti-GAD) for determining prognosis of diabetes type 1 in the Polish population--5 year observation].
    Kretowski A, Szelachowska M, Kinalska I.
    Pol Arch Med Wewn; 1999 Apr; 101(4):323-7. PubMed ID: 10740410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.